Gene expression profiling provides insights into the pathways involved in inflammatory arthritis development: Murine model of Lyme disease

Experimental and Molecular Pathology

Volumn 85, Issue 1, 2008, Pages 20-27

  Miller, Jennifer C ^a   Ma, Ying ^a   Crandall, Hillary ^a   Wang, Xiaohui ^a   Weis, Janis J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Arthritis; Borrelia burgdorferi; Gene regulation; Microarray analysis; Mouse models

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 10; MATRIX METALLOPROTEINASE; TOLL LIKE RECEPTOR 2;

ANKLE; BORRELIA BURGDORFERI; CELL DIFFERENTIATION; CELL INFILTRATION; DISEASE CONTROL; DISEASE SEVERITY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE INDUCTION; GENETIC MANIPULATION; GENETIC SUSCEPTIBILITY; HUMAN; INFLAMMATION; LYME DISEASE; MICROARRAY ANALYSIS; NONHUMAN; QUANTITATIVE TRAIT LOCUS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ARTHRITIS; BORRELIA BURGDORFERI; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; INTERFERONS; LYME DISEASE; MICE; NF-KAPPA B;

BORRELIA BURGDORFERI; MURINAE; MUS; SPIROCHAETALES;

EID: 46749142852     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2008.03.004     Document Type: Review

References (68)

1. Adarichev V.A., et al. Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation. Arthritis Res. Ther. 7 (2005) R196-R207
2. Adarichev V.A., et al. Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation. Arthritis Res. Ther. 7 (2005) R196-R207
3. Aliprantis A.O., et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285 (1999) 736-739
4. Barthold S.W., et al. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162 (1990) 133-138
5. Barthold S.W., et al. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am. J. Pathol. 139 (1991) 263-273
6. Barthold S.W., et al. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am. J. Trop. Med. Hyg. 47 (1992) 605-613
7. Barthold S.W., et al. Chronic Lyme borreliosis in the laboratory mouse. Am. J. Pathol. 143 (1993) 959-971
8. Behera A.K., et al. Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis. Infect. Immun. 73 (2005) 126-134
9. Behera A.K., et al. Identification of a TLR-independent pathway for Borrelia burgdorferi-induced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin alpha 3 beta 1. J. Immunol. 177 (2006) 657-664
10. Benhnia M.R., et al. Signaling through CD14 attenuates the inflammatory response to Borrelia burgdorferi, the agent of Lyme disease. J. Immunol. 174 (2005) 1539-1548
11. Blanco P., et al. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294 (2001) 1540-1543
12. Bolz D.D., et al. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J. Immunol. 173 (2004) 2003-2010
13. Brown C.R., and Reiner S.L. Clearance of Borrelia burgdorferi may not be required for resistance to experimental lyme arthritis. Infect. Immun. 66 (1998) 2065-2071
14. Brown C.R., and Reiner S.L. Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon. Infect. Immun. 67 (1999) 3329-3333
15. Brown C.R., and Reiner S.L. Genetic control of experimental lyme arthritis in the absence of specific immunity. Infect. Immun. 67 (1999) 1967-1973
16. Brown C.R., and Reiner S.L. Genes outside the major histocompatibility complex control resistance and susceptibility to experimental Lyme arthritis. Med. Microbiol. Immunol. (Berl). 189 (2000) 85-90
17. Brown J.P., et al. Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect. Immun. 67 (1999) 5142-5150
18. Brown C.R., et al. Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2. J. Immunol. 171 (2003) 893-901
19. Brown C.R., et al. Treatment of mice with the neutrophil-depleting antibody RB6-8C5 results in early development of experimental lyme arthritis via the recruitment of Gr-1- polymorphonuclear leukocyte-like cells. Infect. Immun. 72 (2004) 4956-4965
20. Burgdorfer W., et al. Lyme disease - a tick-borne spirochetosis?. Science 216 (1982) 1317-1319
21. Crandall H., et al. Gene expression profiling reveals unique pathways associated with differential severity of Lyme arthritis. J. Immunol. 177 (2006) 7930-7942
22. Crow M.K., et al. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 36 (2003) 481-490
23. De Klerck B., et al. Pro-inflammatory properties of stromal cell-derived factor-1 (Cxcl12) in collagen-induced arthritis. Arthritis Res. Ther. 7 (2005) R1208-R1220
24. Fujikado N., et al. Identification of arthritis-related gene clusters by microarray analysis of two independent mouse models for rheumatoid arthritis. Arthritis Res. Ther. 8 (2006) R100-R112
25. Gebbia J.A., et al. Selective induction of matrix metalloproteinases by Borrelia burgdorferi via toll-like receptor 2 in monocytes. J. Infect. Dis. 189 (2004) 113-119
26. Grutz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J. Leukoc. Biol. 77 (2005) 3-15
27. Hayes E.B., and Piesman J. How can we prevent Lyme disease?. N. Engl. J. Med. 348 (2003) 2424-2430
28. Hirschfeld M., et al. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J. Immunol. 163 (1999) 2382-2386
29. Ibrahim S.M., et al. Gene-expression profile of collagen-induced arthritis. J. Autoimmun. 18 (2002) 159-167
30. Kalish R.A., et al. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61 (1993) 2774-2779
31. Lazarus J.J., et al. IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J. Immunol. 177 (2006) 7076-7085
32. Lien E., et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274 (1999) 33419-33425
33. Liu N., et al. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect. Immun. 72 (2004) 3195-3203
34. Ma Y., et al. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect. Immun. 66 (1998) 161-168
35. Mathian A., et al. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black × New Zealand White) F1 but not in BALB/c mice. J. Immunol. 174 (2005) 2499-2506
36. Moore K.W., et al. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
37. Mullegger R.R., et al. Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma. Infect. Immun. 75 (2007) 4621-4628
38. Nanki T., et al. Pathogenic role of the Cxcl16-Cxcr6 pathway in rheumatoid arthritis. Arthritis Rheum. 52 (2005) 3004-3014
39. Narayan K., et al. The nervous system as ectopic germinal center: CXCL13 and IgG in Lyme neuroborreliosis. Ann. Neurol. 57 (2005) 813-823
40. Newman J.C., and Weiner A.M. L2L: a simple tool for discovering the hidden significance in microarray expression data. Genome Biol. 6 (2005) R81.18-R81.81
41. Nocton J.J., and Steere A.C. Lyme disease. Adv. Intern. Med. 40 (1995) 69-117
42. Noppert S.J., et al. The role of type I interferons in TLR responses. Immunol. Cell Biol. 85 (2007) 446-457
43. Norgard M.V., et al. Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B. Infect. Immun. 64 (1996) 3845-3852
44. Rioja I., et al. Gene expression profiles in the rat streptococcal cell wall-induced arthritis model identified using microarray analysis. Arthritis Res. Ther. 7 (2005) R101-R117
45. Roper R.J., et al. Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses. Genes Immun. 2 (2001) 388-397
46. Rosa P.A., et al. The burgeoning molecular genetics of the Lyme disease spirochaete. Nat. Rev. Microbiol. 3 (2005) 129-143
47. Rupprecht T.A., et al. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 65 (2005) 448-450
48. Santiago-Raber M.L., et al. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 197 (2003) 777-788
49. Schurigt U., et al. Local expression of matrix metalloproteinases, cathepsins, and their inhibitors during the development of murine antigen-induced arthritis. Arthritis Res. Ther. 7 (2005)
50. Sellati T.J., et al. Activation of human monocytic cells by Borrelia burgdorferi and Treponema pallidum is facilitated by CD14 and correlates with surface exposure of spirochetal lipoproteins. J. Immunol. 163 (1999) 2049-2056
51. Shahrara S., et al. Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis. Arthritis Rheum. 48 (2003) 3568-3583
52. Steere A.C., et al. The clinical evolution of Lyme arthritis. Ann. Intern. Med. 107 (1987) 725-731
53. Steere A.C., et al. Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Arthritis. Rheum. 31 (1988) 487-495
54. Steere A.C., et al. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N. Engl. J. Med. 323 (1990) 219-223
55. Steere A.C., et al. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 48 (2003) 534-540
56. Steere A.C., and Glickstein L. Elucidation of Lyme arthritis. Nat. Rev. Immunol. 4 (2004) 143-152
57. Strueby L., et al. Arthritis and bursitis in multiple sclerosis patients treated with interferon-beta. Scand. J. Rheumatol. 34 (2005) 485-488
58. Szekanecz Z., et al. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheum. 43 (2000) 1266-1277
59. Uematsu S., and Akira S. Toll-like receptors and type I interferons. J. Biol. Chem. 282 (2007) 15319-15323
60. Wang X., et al. Relative contributions of innate and acquired host responses to bacterial control and arthritis development in Lyme disease. Infect. Immun. 73 (2005) 657-660
61. -/- mice. FEMS Immunol. Med. Microbiol. 52 (2008) 124-133
62. Weis J.J., et al. Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease. J. Immunol. 162 (1999) 948-956
63. Wilson L.E., et al. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin. Arthritis Rheum. 32 (2002) 163-173
64. Wooten R.M., et al. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J. Immunol. 160 11 (1998) 5485-5492
65. Wooten R.M., et al. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J. Immunol. 168 1 (2002) 348-355
66. Wooten R.M., and Weis J.J. Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. Curr. Opin. Microbiol. 4 (2001) 274-279
67. Yang L., et al. Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect. Immun. 60 (1992) 3033-3041
68. Zheng B., et al. Cxcl13 neutralization reduces the severity of collagen-induced arthritis. Arthritis Rheum. 52 (2005) 620-626